Fwd: First Cancer Diagnostic Test Based On Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval (Medical News Today)

---------- Forwarded message ----------
From: Yahoo! News Search Results for mesothelioma diagnosis <rssfwd@rssfwd.com>
Date: Thu, Jul 24, 2008 at 7:44 AM
Subject: First Cancer Diagnostic Test Based On Rosetta Genomics' Proprietary MicroRNA Technology Receives Regulatory Approval (Medical News Today)
To: collegeschoolloan@gmail.com


Rosetta Genomics, Ltd. (NASDQ: ROSG) announces that the first molecular test based on Rosetta Genomics' proprietary microRNA technology, developed and validated by Columbia University Medical Center (CUMC), has been approved for clinical use by the New York State Department of Health Clinical Laboratory Evaluation Program.

Wed, 23 Jul 2008 11:12:47 GMT

___
Source: http://us.rd.yahoo.com/dailynews/rss/search/mesothelioma+diagnosis/SIG=11n7kj7a4/*http%3A//www.medicalnewstoday.com/articles/115853.php
--
 Powered by [4]RssFwd, a service of [5]Blue Sky Factory, Inc